Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Publication of Final Terms

21st Jan 2026 15:08

RNS Number : 8336P
Bank of Montreal
21 January 2026
 

Please have this filed under the headline "Publication of Final Terms"

 

Regulatory Announcement

 

 

Bank of Montreal

21 January 2026

 

Publication of Final Terms

 

 

Not for release, publication or distribution, directly or indirectly, in or into the United States.

 

Bank of Montreal agreed to issue 1,500,000,000 2.75%per cent. Covered Bonds due 21 January 2031, Series CBL38, on 19 January 2026 (the "Covered Bonds") under the U.S.$50,000,000,000 Global Registered Covered Bond Program of Bank of Montreal, unconditionally and irrevocably guaranteed as to payments of interest and principal by BMO Covered Bond Guarantor Limited Partnership.

 

The following document constitutes the Final Terms Document dated 19 January 2026 (the "Final Terms") relating to the admission to trading of the Covered Bonds for purpose of Article 8 of Regulation (EU) 2017/1129 as it forms part of domestic law of the UK by virtue of the European Union (Withdrawal) Act 2018 and must be read in conjunction with the Prospectus dated 10 September 2025, as supplemented by the 1st Supplement dated 15 December 2025 (together, the "Prospectus"). Full information on Bank of Montreal and the offer of the Covered Bonds is only available on the basis of the combination of the Final Terms and the Prospectus.

 

The Final Terms have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

DISCLAIMER - INTENDED ADDRESSEES

 

Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms you must ascertain from the Prospectus, as supplemented by these Final Terms, whether or not you are part of the intended addressees of the information contained therein.

 

In particular, the Covered Bonds and the Covered Bond Guarantee have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States. Subject to certain exceptions, the Covered Bonds may not be offered, sold or delivered, directly or indirectly, in the United States or to or for the account or benefit of a "U.S. person" (as defined in Regulation S under the Securities Act).  No public offering of the Covered Bonds is being made in the United States. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.

 

Your right to access this service is conditional upon complying with the above requirement.

 

UK MiFIR professionals / MiFID II professionals / ECPs-only - Manufacturer target market (UK MiFIR product governance and MiFID II product governance) is eligible counterparties and professional clients only (all distribution channels). No PRIIPs key information document (KID) has been prepared as not available to retail in the EEA or the UK.

 

To view the Final Terms, please paste the following URL into the address bar of your browser.

 

http://www.rns-pdf.londonstockexchange.com/rns/8336P_1-2026-1-21.pdf

 

 

 

Zoë Kruis

Corporate Secretary's Dept.

Phone: (437) 775-8791

Email: [email protected]

 

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFTAKDBKPBKDPDB
FTSE 100 Latest
Value10,195.57
Change57.48